iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Investing Activities (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Cash from Investing Activities came in at -$1.6 million in Q1 2026, down 114.51% year-on-year from $11.1 million in Q1 2025, and up 78.71% quarter-over-quarter from -$7.6 million in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Investing Activities (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$1.6 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$1.6 million, down 114.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 282.2% YoY), and the FY2025 annual result was $2.3 million, up 136.57% from the prior year.
  • Cash from Investing Activities came in at -$1.6 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from -$7.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $11.1 million in Q1 2025 to a low of -$7.6 million in Q4 2025.
  • The 5-year median for Cash from Investing Activities is -$1.2 million (2024), against an average of -$866235.3.
  • Across the five-year window, Cash from Investing Activities slumped 2620.47% in 2024 and jumped 1342.39% in 2025, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Cash from Investing Activities stood at -$1.2 million in 2022, then surged by 89.23% to -$127000.0 in 2023, then plunged by 2620.47% to -$3.5 million in 2024, then sank by 119.16% to -$7.6 million in 2025, then surged by 78.71% to -$1.6 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$1.6 million (Q1 2026), -$7.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn -1.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.61 Mn
Mar 31, 2026 -1.61 Mn
Dec 31, 2025 -7.57 Mn
Dec 31, 2025 -7.57 Mn
Sep 30, 2025 2.05 Mn
Sep 30, 2025 2.05 Mn
Jun 30, 2025 -3.29 Mn
Jun 30, 2025 -3.29 Mn
Mar 31, 2025 11.11 Mn
Mar 31, 2025 11.11 Mn
Dec 31, 2024 -3.46 Mn
Dec 31, 2024 -3.46 Mn
Sep 30, 2024 -776,000.00
Sep 30, 2024 -776,000.00
Jun 30, 2024 -1.16 Mn
Jun 30, 2024 -1.16 Mn
Mar 31, 2024 -894,000.00
Mar 31, 2024 -894,000.00
Dec 31, 2023 -127,000.00
Dec 31, 2023 -127,000.00